• Compare Products
Menu
Account
Due to pandemic-related plasticware shortages, you may see temporary changes to product packaging. Product quantity and quality are unaffected.

STEMdiff™ Trilineage Differentiation Kit

Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers

Loading...

STEMdiff™ Trilineage Differentiation Kit

Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers

From: 691 USD
Catalog #
05230_C
Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers

Product Advantages


  • Reproducible differentiation to all three germ layers across multiple pluripotent cell lines

  • Easy-to-interpret assay results

  • Complete, defined culture media

  • Standardized, one-week protocol

What's Included

  • STEMdiff™ Trilineage Ectoderm Medium, 175 mL
  • STEMdiff™ Trilineage Mesoderm Medium, 100 mL
  • STEMdiff™ Trilineage Endoderm Medium, 100 mL
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.
  1. ACCUTASE™
    ACCUTASE™

    Cell detachment solution

  2. Y-27632 (Dihydrochloride)
    Y-27632 (Dihydrochloride)

    RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2

  3. mTeSR™1
    mTeSR™1

    cGMP, feeder-free maintenance medium for human ES and iPS cells

  4. Gentle Cell Dissociation Reagent
    Gentle Cell Dissociation Reagent

    cGMP, enzyme-free cell dissociation reagent

Overview

The STEMdiff™ Trilineage Differentiation Kit provides a simple culture assay to functionally validate the ability of new or established human embryonic stem (ES) and induced pluripotent stem (iPS) cell lines to differentiate to the three germ layers: ectoderm, mesoderm, and endoderm. This kit includes specialized, complete media and monolayer-based protocols to perform parallel in vitro directed differentiation experiments for each germ layer, clearly and reproducibly establishing trilineage differentiation potential within one week. STEMdiff™ Trilineage Differentiation Kit is intended to be an endpoint assay and is not optimized for the generation of cells for downstream differentiation or other applications. STEMdiff™ Trilineage Differentiation Kit has been optimized to assess cells maintained in mTeSR™1.
Subtype
Specialized Media
Cell Type
Pluripotent Stem Cells
Species
Human
Application
Cell Culture, Characterization, Differentiation, Functional Assay, Phenotyping
Brand
STEMdiff
Area of Interest
Stem Cell Biology

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Information Sheet
Product Name
STEMdiff™ Trilineage Differentiation Kit
Catalog #
05230
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
STEMdiff™ Trilineage Differentiation Kit
Catalog #
05230
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
STEMdiff™ Trilineage Differentiation Kit
Catalog #
05230
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Product Name
STEMdiff™ Trilineage Differentiation Kit
Catalog #
05230
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Research Area
Workflow Stages

Resources and Publications

Educational Materials (31)

Products for Human Pluripotent Stem Cells
Brochure
Products for Human Pluripotent Stem Cells
hPSC-Derived Cell Therapy Workflow
Brochure
hPSC-Derived Cell Therapy Workflow
STEMdiff™ Trilineage Differentiation Kit
Brochure
STEMdiff™ Trilineage Differentiation Kit
qPCR Arrays for Cell Characterization
Brochure
qPCR Arrays for Cell Characterization
2019-2020 Cell Culture Training Catalog
Brochure
2019-2020 Cell Culture Training Catalog
Directed Differentiation of Pluripotent Stem Cells
Wallchart
Directed Differentiation of Pluripotent Stem Cells
Derivation and Applications of Human Pluripotent Stem Cells
Wallchart
Derivation and Applications of Human Pluripotent Stem Cells
How to Set Up an Assay with the hPSC Genetic Analysis Kit Experiment
8:33
Video
How to Set Up an Assay with the hPSC Genetic Analysis Kit Experiment
How to Maintain and Assess Morphology of Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
3:35
Video
How to Maintain and Assess Morphology of Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
How to Transition Human Pluripotent Stem Cells into mTeSR™ Plus from Other Feeder-Free Media
1:29
Video
How to Transition Human Pluripotent Stem Cells into mTeSR™ Plus from Other Feeder-Free Media
How to Coat Plates for Human Pluripotent Stem Cell (hPSC) Cultures in mTeSR™ Plus
5:20
Video
How to Coat Plates for Human Pluripotent Stem Cell (hPSC) Cultures in mTeSR™ Plus
How to Generate Cell Aggregates and Passage Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
7:57
Video
How to Generate Cell Aggregates and Passage Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
From hPSCs to Immune Cells: Immune Cell Generation from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures
26:18
Webinar
From hPSCs to Immune Cells: Immune Cell Generation from Human Pluripotent Stem Cells in Feeder- and ...
STEMdiff™ Kits for Robust and Efficient Differentiation of hPSCs to Multiple Cell Types
20:24
Webinar
STEMdiff™ Kits for Robust and Efficient Differentiation of hPSCs to Multiple Cell Types
Survey Results: Insights and Trends in Pluripotent Stem Cell Research
13:58
Webinar
Survey Results: Insights and Trends in Pluripotent Stem Cell Research
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
50:01
Webinar
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
33:47
Webinar
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Bank...
Development, Compatibility, and Applications of mTeSR™ Plus; an Enhanced Medium for the Maintenance of Human Pluripotent Stem Cells (hPSCs)
42:10
Webinar
Development, Compatibility, and Applications of mTeSR™ Plus; an Enhanced Medium for the Maintenanc...
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
71:57
Webinar
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Differentiation of High-Quality hPSCs Using STEMdiff™ and TeSR™-AOF
12:44
Webinar
Differentiation of High-Quality hPSCs Using STEMdiff™ and TeSR™-AOF
iPSCs As Models, Part 1: What Are Induced Pluripotent Stem Cells and How Do You Use Them?
37:18
Webinar
iPSCs As Models, Part 1: What Are Induced Pluripotent Stem Cells and How Do You Use Them?
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
1:13:44
Webinar
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
Best Practice Criteria for Pluripotent Stem Cell Lines
55:52
Webinar
Best Practice Criteria for Pluripotent Stem Cell Lines
Nature Research Round Table: Pluripotency Tests
17:46
Webinar
Nature Research Round Table: Pluripotency Tests
Maintaining and Assessing High-Quality hPSC Cultures
55:53
Webinar
Maintaining and Assessing High-Quality hPSC Cultures
From hPSCs to Immune Cells: Generating Dendritic Cells by Direct Cell Reprogramming
29:36
Webinar
From hPSCs to Immune Cells: Generating Dendritic Cells by Direct Cell Reprogramming
Human Pluripotent Stem Cells for the Treatment of Age-Related Macular Degeneration and Compliance Considerations for Clinical-Grade iPSCs
47:23
Webinar
Human Pluripotent Stem Cells for the Treatment of Age-Related Macular Degeneration and Compliance Co...
Improving Reproducibility of Your hPSC Research by Generating a High-Quality Cell Bank
21:53
Webinar
Improving Reproducibility of Your hPSC Research by Generating a High-Quality Cell Bank
Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro
20:09
Webinar
Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro
hPSC Quality: Essential Considerations for Gene Editing, Cloning, Maintenance and Disease Modeling
50:49
Webinar
hPSC Quality: Essential Considerations for Gene Editing, Cloning, Maintenance and Disease Modeling
Rapid Assessment of Pluripotency Using Directed Differentiation to all Three Germ Layers
Scientific Poster
Rapid Assessment of Pluripotency Using Directed Differentiation to all Three Germ Layers

Publications (3)

Feeder-Free Derivation of Naïve Human Pluripotent Stem Cells. Ward E et al. Stem cells and development 2017 MAY

Abstract

Human pluripotent stem cells (HPSCs) cultured in conditions that maintain pluripotency via FGF and TGFβ signaling have been described as being in a primed state. These cells have been shown to exhibit characteristics more closely related to mouse epiblast-derived stem cells than to so called naïve mouse PSCs said to possess a more ground state pluripotency that mimics the early mouse embryo inner cell mass. Initial attempts to create culture conditions favorable for generation of naïve HPSCs from primed HPSCs has required the use of mouse embryonic fibroblasts as a feeder layer to support this transition. A protocol for the routine derivation and maintenance of naïve HPSCs in completely defined conditions is highly desirable for stem cell researchers to enhance the study and clinical translation of naïve HPSCs. Here we describe a standard protocol for transitioning primed HPSCs to a naïve state using commercial RSet media and xeno-free recombinant vitronectin.
View publication
Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy. S. B. Ross et al. Stem cell research 2017

Abstract

Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) obtained from a 62-year-old female with familial hypertrophic cardiomyopathy (HCM). PBMCs were reprogrammed to a pluripotent state following transfection with non-integrative episomal vectors carrying reprogramming factors OCT4, SOX2, LIN28, KLF4 and L-MYC. iPSCs were shown to express pluripotency markers, possess trilineage differentiation potential, carry rare variants identified in DNA isolated directly from the patient's whole blood, have a normal karyotype and no longer carry episomal vectors for reprogramming. This line is a useful resource for identifying unknown genetic causes of HCM.
View publication
Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene. S. B. Ross et al. Stem cell research 2017

Abstract

Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) isolated from the whole blood of a 43-year-old male with hypertrophic cardiomyopathy (HCM) who carries the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7). Patient-derived PBMCs were reprogrammed using non-integrative episomal vectors containing reprogramming factors OCT4, SOX2, LIN28, KLF4 and L-MYC. iPSCs were shown to express pluripotent markers, have trilineage differentiation potential, carry the pathogenic MYH7 variant p.Val698Ala, have a normal karyotype and no longer carry the episomal reprogramming vector. This line is useful for studying the link between variants in MYH7 and the pathogenesis of HCM.
View publication
View All Publications

Related Products

Related Products

Quality Statement:

PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.

Copyright © 2023 by STEMCELL Technologies. All rights reserved.
  • Privacy
  • Terms & Conditions
  • xw